Mojgan Amiri1,2, Hamidreza Raeisi-Dehkordi1,2, Fatemeh Moghtaderi1,2, Alireza Zimorovat1,2, Matin Mohyadini3,4, Amin Salehi-Abargouei5,6. 1. Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. 2. Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, PO Code 8915173160, Iran. 3. Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. 4. Department of Medical Laboratory Sciences, School of Para Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. 5. Nutrition and Food Security Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. abargouei@ssu.ac.ir. 6. Department of Nutrition, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, PO Code 8915173160, Iran. abargouei@ssu.ac.ir.
Abstract
AIMS: To compare the effects of replacing regular dietary oils intake with sesame (SO), canola (CO), and sesame-canola (SCO) oils (a novel blend), on cardiometabolic markers in adults with type 2 diabetes mellitus (T2DM), in a triple-blind, three-way, randomized, crossover clinical trial. METHODS: Participants were assigned to receive SO, CO, and SCO in three 9-week phases (4 weeks apart). Cardiometabolic makers (serum lipids, Apolipoprotein, cardiovascular risk scores, kidney markers, and blood pressure) were considered at the beginning and the end of intervention phases. RESULTS: Ninety-two, ninety-five, and ninety-five participants completed the SO, SCO, and CO periods, respectively. After CO consumption, serum Apo A-1 concentrations were significantly higher compared with the SCO period in the whole population (p < 0.05). A considerable reduction in visceral adiposity index values was seen in the CO compared with the SO period in males (p < 0.05). Serum high-density lipoprotein concentration was also significantly higher after the SO intake compared with SCO in females (p < 0.05). The between-period analysis showed a substantial reduction in diastolic blood pressure in the SCO period compared with the CO and SO periods and lower systolic blood pressure after SCO versus CO intake in males (p < 0.05). CONCLUSIONS: Canola oil might protect CVD through improving Apo A-1 levels in patients with T2DM (particularly in females) and visceral adiposity index in male patients. However, the blend oil might beneficially affect blood pressure in men. Future sex-specific studies might warrant the current findings. REGISTRY OF CLINICAL TRIALS: This trial was registered in the Iranian Registry of Clinical Trials (IRCT, registration ID: IRCT2016091312571N6).
AIMS: To compare the effects of replacing regular dietary oils intake with sesame (SO), canola (CO), and sesame-canola (SCO) oils (a novel blend), on cardiometabolic markers in adults with type 2 diabetes mellitus (T2DM), in a triple-blind, three-way, randomized, crossover clinical trial. METHODS: Participants were assigned to receive SO, CO, and SCO in three 9-week phases (4 weeks apart). Cardiometabolic makers (serum lipids, Apolipoprotein, cardiovascular risk scores, kidney markers, and blood pressure) were considered at the beginning and the end of intervention phases. RESULTS: Ninety-two, ninety-five, and ninety-five participants completed the SO, SCO, and CO periods, respectively. After CO consumption, serum Apo A-1 concentrations were significantly higher compared with the SCO period in the whole population (p < 0.05). A considerable reduction in visceral adiposity index values was seen in the CO compared with the SO period in males (p < 0.05). Serum high-density lipoprotein concentration was also significantly higher after the SO intake compared with SCO in females (p < 0.05). The between-period analysis showed a substantial reduction in diastolic blood pressure in the SCO period compared with the CO and SO periods and lower systolic blood pressure after SCO versus CO intake in males (p < 0.05). CONCLUSIONS: Canola oil might protect CVD through improving Apo A-1 levels in patients with T2DM (particularly in females) and visceral adiposity index in male patients. However, the blend oil might beneficially affect blood pressure in men. Future sex-specific studies might warrant the current findings. REGISTRY OF CLINICAL TRIALS: This trial was registered in the Iranian Registry of Clinical Trials (IRCT, registration ID: IRCT2016091312571N6).
Authors: Maria Inês Schmidt; Bruce B Duncan; Heejung Bang; James S Pankow; Christie M Ballantyne; Sherita H Golden; Aaron R Folsom; Lloyd E Chambless Journal: Diabetes Care Date: 2005-08 Impact factor: 19.112
Authors: P M Kris-Etherton; T A Pearson; Y Wan; R L Hargrove; K Moriarty; V Fishell; T D Etherton Journal: Am J Clin Nutr Date: 1999-12 Impact factor: 7.045
Authors: Damian T Roland; Andrew Rowland; Sarah Cotterill; Calvin Heal; Steve Woby; Natalie Garratt; Stephen Brown; Tony Long Journal: BMJ Date: 2019-10-31
Authors: Marta Guasch-Ferré; Nerea Becerra-Tomás; Miguel Ruiz-Canela; Dolores Corella; Helmut Schröder; Ramon Estruch; Emilio Ros; Fernando Arós; Enrique Gómez-Gracia; Miquel Fiol; Lluís Serra-Majem; José Lapetra; Josep Basora; Nerea Martín-Calvo; Olga Portoles; Montserrat Fitó; Frank B Hu; Lluís Forga; Jordi Salas-Salvadó Journal: Am J Clin Nutr Date: 2017-02-15 Impact factor: 7.045
Authors: Harmon Eyre; Richard Kahn; Rose Marie Robertson; Nathaniel G Clark; Colleen Doyle; Yuling Hong; Ted Gansler; Thomas Glynn; Robert A Smith; Kathryn Taubert; Michael J Thun Journal: Circulation Date: 2004-06-15 Impact factor: 29.690
Authors: Caroline S Fox; Sherita Hill Golden; Cheryl Anderson; George A Bray; Lora E Burke; Ian H de Boer; Prakash Deedwania; Robert H Eckel; Abby G Ershow; Judith Fradkin; Silvio E Inzucchi; Mikhail Kosiborod; Robert G Nelson; Mahesh J Patel; Michael Pignone; Laurie Quinn; Philip R Schauer; Elizabeth Selvin; Dorothea K Vafiadis Journal: Circulation Date: 2015-08-05 Impact factor: 29.690